What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.41%Above 5Y avg (1.35%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
13.2%Sustainable
Payback Period
72.0 yr
Last Ex-Dividend
Jun 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.06BCNY
602.32M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
37.29x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
1.43BCNY
212.41M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
7.55%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.2980x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-16.55%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
4.06BCNY
602.32M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
3.26BCNY
483.47M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
37.29x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
2.84x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Book (MRQ)
3.14x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
2.28x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
20.27x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.28×.Updated Aug 20, 2026
Gross Margin
28.10%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 22.94%.Updated Aug 20, 2026
Profit Margin
7.55%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
11.00%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
4.25%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
8.53%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
1.43BCNY
212.41M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
5.04CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
12.40%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
328.08MCNY
48.73M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
199.93MCNY
29.69M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
107.97MCNY
16.04M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-39.20%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
201.71MCNY
29.96M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
115.27MCNY
17.12M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.2000CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
1.41%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
1.35%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
13.16%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 52.63%.Updated Aug 20, 2026
Minority Interest (Equity)
-715.20KCNYFY2025 · Dec 31, 2025
Revenue
1.40BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.06BCNYFY2025 · Dec 31, 2025
Gross Profit
344.85MCNYFY2025 · Dec 31, 2025
Operating Income
146.20MCNY
21.71M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
150.21MCNYFY2025 · Dec 31, 2025
Income Tax Expense
29.05MCNYFY2025 · Dec 31, 2025
Net Income
121.16MCNYFY2025 · Dec 31, 2025
EBIT
150.57MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
199.93MCNYFY2025 · Dec 31, 2025
Research & Development
86.12MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
64.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.04MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
367.62KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
284.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
284.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
121.16MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.22MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-30.73MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-127.42MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
804.77MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
121.16MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.98MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-75.44MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-81.43MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-96.69MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.16BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.24BCNYFY2025 · Dec 31, 2025
Other Investing Activity
15.94MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
1.51MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
37.90MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-14.64MCNYFY2025 · Dec 31, 2025
Other Financing Charges
98.60KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
23.36MCNYFY2025 · Dec 31, 2025
Shares Outstanding
286.20MSharesUpdated Aug 20, 2026
Float Shares
80.30MSharesUpdated Aug 20, 2026
% Held by Insiders
70.50%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
2.31%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
838.51MCNY
124.54M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
2.93CNYUpdated Aug 20, 2026
Total Debt (MRQ)
38.68MCNY
5.74M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0300x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.34x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
4.51CNYUpdated Aug 20, 2026
Total Assets
1.98BCNY
294.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.50BCNYFY2025 · Dec 31, 2025
Total Liabilities
712.62MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
476.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
21.60MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
691.02MCNYFY2025 · Dec 31, 2025
Cash
804.76MCNYFY2025 · Dec 31, 2025
Cash Equivalents
101.44MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
906.19MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
40.07MCNYFY2025 · Dec 31, 2025
Accounts Receivable
356.50MCNYFY2025 · Dec 31, 2025
Inventory
137.81MCNYFY2025 · Dec 31, 2025
Accounts Payable
571.12MCNYFY2025 · Dec 31, 2025
Short-term Debt
40.16MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.66MCNYFY2025 · Dec 31, 2025
Long-term Debt
747.83KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.68MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
286.20MCNYFY2025 · Dec 31, 2025
Retained Earnings
638.61MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.27BCNY
188.33M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.61CNYUpdated Aug 20, 2026
52-Week High
27.65CNYUpdated Aug 20, 2026
52-Week Change
-16.55%
vs all stocks
Updated Aug 20, 2026
Beta
0.2980x
vs all stocks
Updated Aug 20, 2026
50-Day MA
15.17CNYUpdated Aug 20, 2026
200-Day MA
19.49CNYUpdated Aug 20, 2026
Avg 10-Day Volume
2.18MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
2.83MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.3800CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.